Bellevue Group AG raised its stake in shares of MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 1.5% in the fourth quarter, Holdings Channel.com reports. The firm owned 9,953,313 shares of the biopharmaceutical company’s stock after buying an additional 150,000 shares during the period. MacroGenics comprises approximately 1.5% of Bellevue Group AG’s investment portfolio, making the […]